Reuters logo
BRIEF-Zealand Pharma Initiates Phase 3 Trial With Dasiglucagon
December 7, 2017 / 2:44 PM / in 6 days

BRIEF-Zealand Pharma Initiates Phase 3 Trial With Dasiglucagon

Dec 7 (Reuters) - Zealand Pharma A/S:

* ZEALAND PHARMA INITIATES THE PIVOTAL PHASE 3 TRIAL WITH DASIGLUCAGON FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA IN DIABETES

* SAYS RESULTS FROM PHASE 3 TRIAL EXPECTED IN H2 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below